We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.
Novartis Immunology Portfolio Update
October 30, 2025 | Basel, Switzerland
Watch the webcast
Download the podcast (MP3 35 MB)
Download the presentation (PDF 2.5 MB)
Third quarter results 2025
October 28, 2025 | Basel, Switzerland
Press release: English (PDF 0.3 MB) | Deutsch (PDF 0.3 MB)
Interim financial report (PDF 0.4 MB)
Watch the webcast
Download the podcast (MP3 31 MB)
Download the presentation (PDF 5.6 MB)
Novartis agrees to acquire Avidity Biosciences
October 27, 2025 | Basel, Switzerland
Watch the webcast
Download the podcast (MP3 25 MB)
Download the presentation (PDF 0.8 MB)
Read the press release
Investors event calendar
View recent presentations and learn more about upcoming events.
November 11, 2025
Guggenheim Global Healthcare Conference
Boston, USA
Environmental, Social and Governance (ESG)
Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.
ESG updates: July 2025 (PDF 0.8 MB) | May 2025 (PDF 0.9 MB) | February 2025 (PDF 1.0 MB) | October 2024 (PDF 0.6 MB)
Latest updates: Impact & Sustainability (PDF 1.9 MB) | Impact & Health Equity (PDF 9.9 MB) | Novartis Enterprise Risk Management (PDF 0.2 MB)
We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.
Stocks
Reporting and transparency hub
Read our regulatory filings; policies, codes and guidelines that govern our activities; and environmental, social and governance (ESG) disclosures.